Regenerative Medicine and Cell Therapies Virtual Event

Sorry guys for opening a new thread. I have created just because its to have sperate information for each event. this is a very important event and the timing is just perfect.

Thanks, guys for sharing information for those who missed tonight. This will be a piece of very insightful information getting form this event.

Look at who is from the Mesoblast side discussed on which topic, quite interesting. If we can find out the transcript of this event would be the gold standard information.

http://regmedcelltherapypolicy.org/agenda/


1. Insights on Outcomes from Use of MSCs for Patients with COVID-19-

Joanne Kurtzberg, MD (Don't need an explanation of her profile, we all know who is she?

2. Conversation with Industry Leader-

David Oxley, Senior Vice President, Business Development and Licensing, Mesoblast

Bernard Siegel, Executive Director, Regenerative Medicine; Founder and Chair, World Stem Cell Summit

3. Virtual Fireside Chat with Current and Former Administration Leaders

Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research, Food and Drug Administration

Robert M. Califf, MD, PhD, Head of Health Strategy and Policy, Google and Verily Health; Former Commissioner, Food and Drug Administration

Andrew von Eschenbach, MD, President, Samaritan Health Initiatives, Inc.; Adjunct Professor, University of Texas MD Anderson Cancer Center; Former Commissioner, Food and Drug Administration; Former Director, National Cancer Institute

4. Scaling Manufacturing of Cell Therapies: Current Capabilities, Key Strategies for Moving Forward

John McMannis, PhD, Executive Vice President, Manufacturing, Mesoblast

Who is John McMannis- http://regmedcelltherapypolicy.org/john-mcmannis-phd/